- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02988570
Study on the Phenotype of Language in Preterm Born Children at 5 Years of Age (EPILANG2)
In recent years, several studies confirm that some of preterm children have language developmental disabilities, in production, in comprehension, or in written language. These language impairments lead to learning disabilities. There are, however, contradictions concerning the origin and nature of language dysfunctions. Some studies find lexical disorders (number of words used by the child), others preferentially phonological disorders (sounds used in the language), others also disorders of the morphosyntaxe (organization of the sentences) and fragilities that affect pragmatics (understanding situations).
The computer-evaluation of the language is carried out at five and a half year coupled with the medical and neuropsychological examinations. The language assessment lasts 30 to 45 minutes per child. It is carried out using a laptop computer that allows the submission of stimuli and recording of the child's responses. The language evaluation scale is the battery CléA (Pasquet F et al, 2014), standardized reference tool for the realization of a language evaluation. The assessment includes three tests: comprehension of words and phrases, production of words and phrases, and judgment of sentences. Each time, the child sees images and hears words or phrases. Sometimes he has to say what he sees on the computer screen.
As usual, a speech-language assessment is not carried out, routinely, at the age of 5 years in the context of the follow-up of children born very preterm.
The evaluation proposed to the child in this research will be carried out at a significant period of development, before writing. This assessment will not only assess the structure of the child's language, but also determine if there are possible difficulties in learning to read and write.
The expected benefits for the health of the children included in the trial therefore concern the detection or characterization of any developmental fragilities affecting the language. These screenings or characterizations will make it possible to advocate a speech rehabilitation if necessary.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rouen, France
- Rouen University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children born very preterm in 2011 in the region of Haute-Normandie in France
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: children born very preterm
A computer-evaluation of the language will be done for children born very preterm preterm in 2011 in the region of Haute-Normandie in France
|
A computer-evaluation of the language will be done for children born very preterm preterm in 2011 in the region of Haute-Normandie in France
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of comprehension of words and phrases level
Time Frame: Day 1
|
A computer-based language evaluation battery (Cléa) comprising standardized test to evaluate comprehension of words and phrases will be used.
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of production of words and phrases level
Time Frame: Day 1
|
A computer-based language evaluation battery (Cléa) comprising standardized test to evaluate production of words and phrases level will be used.
|
Day 1
|
Evaluation of judgment of sentences level
Time Frame: Day 1
|
A computer-based language evaluation battery (Cléa) comprising standardized test to evaluate judgment of sentences level will be used.
|
Day 1
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stéphane MARRET, Pr, Rouen University Hospital
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/338/HP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Children
-
National Taiwan University HospitalUnknown
-
National Cheng-Kung University HospitalNot yet recruitingDevelopmental Delay | Preterm Children
-
Assistance Publique Hopitaux De MarseilleCompletedCHILDREN BORN VERY PRETERM AT SCHOOL-AGEFrance
-
University Hospital, CaenNational Research Agency, FranceUnknown
-
Nantes University HospitalRecruiting
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaboratorsCompletedTerm and Preterm Neonates (24-41 Weeks Gestational Age) | Hematopoietic Stem Cell Transplant Recipient ChildrenFrance
-
American University of Beirut Medical CenterRecruitingEarly Intervention | Behavioral Assessment of ChildrenLebanon
-
Istanbul University - Cerrahpasa (IUC)CompletedPreterm Labor | Preterm Spontaneous Labor With Preterm Delivery | Preterm Labor With Preterm Delivery in Third TrimesterTurkey
-
AMAG Pharmaceuticals, Inc.Registrat-MapiCompletedChildren Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy TrialUnited States, Spain, Russian Federation, Canada, Czechia, Hungary, Ukraine
Clinical Trials on computer-evaluation of the language
-
Institut National de la Santé Et de la Recherche...Terminated
-
National Institute on Deafness and Other Communication...Completed
-
Taipei Medical University HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Hospices Civils de LyonRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Florida Department of HealthCompleted
-
Assiut UniversityNot yet recruiting
-
Ankara Yildirim Beyazıt UniversityCompletedType 2 Diabetes Mellitus | BalanceTurkey
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingCochlear Implantation | Profound Congenital DeafnessFrance
-
Vastra Gotaland RegionSahlgrenska University Hospital, Sweden; The Göteborg Medical Society, SwedenCompletedEsophageal Cancer | Dysphagia, EsophagealSweden